Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

MicroVision Stock Is a Bad Bet on a Short-Squeeze and a Worse Bet on Lidar

By Thomas Niel, InvestorPlace Contributor

There may still be short-squeeze potential here, but this too is hardly a reason to buy. The "Reddit effect" is no longer as strong as it once was. The risk of big losses overshadowing the potential for another round of squeeze-fueled gains. Bottom line: your best move with MVIS stock remains the same. Stay away.

8 Reddit Penny Stocks That May Withstand the Market Maelstrom

By Thomas Niel, InvestorPlace Contributor

Looming uncertainty may be bad news for most Reddit penny stocks, but these eight may hold onto their gains, or head higher, from here.

Keep on Avoiding Nio Stock, as Signs Point to Even Lower Prices

By Thomas Niel, InvestorPlace Contributor

Expect Nio's current hiccups to continue putting downward pressure on NIO stock. Not yet finding its floor, its share price could still drift back below $30 per share.

It Won’t Take Much for Vaxart Stock to Pop Once Again

By Thomas Niel, InvestorPlace Contributor

This is a risky play, with a catalyst that more likely than not won't pan out. But, if it releases more promising news within the coming months, it could go on yet another parabolic run. Approach VXRT stock cautiously, but as its share price retreats, now may be the time to pounce.

7 Reddit Penny Stocks Promising to Cure Cancer

By Thomas Niel, InvestorPlace Contributor

These seven risky Reddit penny stocks are in the biotech space and the business of developing cancer therapies and treatments.

Beaten-Down Tilray Stock May be Worth the Risk

By Thomas Niel, InvestorPlace Contributor

It's too early to tell whether its recent combination with Aphria will succeed, but consider TLRY stock a cautious buy after its sell-off.

With Even More Bad News, Dogecoin’s Time Might Be Up

By Thomas Niel, InvestorPlace Contributor

It may not go back to below a penny. But expect Dogecoin to give up even more of its recent gains.

All Bets Are Off on Where Amazon Stock Goes From Here

By Thomas Niel, InvestorPlace Contributor

AMZN stock has held steady since September and will likely see double-digit growth in 2021 and 2022. But it's hard to tell whether that'll continue if we see a correction.

7 Small-Cap Biotech Stocks to Watch for Upcoming Catalysts

By Thomas Niel, InvestorPlace Contributor

Small-cap stocks in the biotech space have been in a slump, but these seven companies could see big moves just around the corner.

Don’t Chase the Next Palantir Stock Bounce Back

By Thomas Niel, InvestorPlace Contributor

Depending on how things play out, growth stocks like this could be in for an additional correction. And even once it bottoms out, it could be years before it starts delivering strong returns for investors once again. So what's the best move now with PLTR stock? Steer clear and don't chase the next bounce back.

Load More